Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cutaneous manifestations associated with immune checkpoint inhibitors
Tomoya Watanabe, Yukie Yamaguchi
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Application of oncolytic virus in tumor therapy
Zhijian Huang, Hongen Guo, Lin Lin, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Closed Access | Times Cited: 25
Molecular Mechanisms of Cutaneous Immune-Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitors
Yi-Shan Teng, Sebastian Yu
Current Oncology (2023) Vol. 30, Iss. 7, pp. 6805-6819
Open Access | Times Cited: 24
Immune-Related Adverse Events Due to Cancer Immunotherapy: Immune Mechanisms and Clinical Manifestations
Silvia Casagrande, Giulia Boscato Sopetto, Giovanni Bertalot, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1440-1440
Open Access | Times Cited: 13
Diagnosis and Management of Skin Toxicities in Systemic Treatment of Genitourinary Cancers
Deepro Chowdhury, Laura D Chin, Roupen Odabashian, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 251-251
Open Access
Atezolizumab-Induced Generalized Cutaneous Lichen Planus in a Patient With Metastatic Small Cell Lung Cancer Successfully Treated With Isotretinoin: A Case Report
Cătălina-Ioana Naum, Beatrice Bălăceanu-Gurău, Alexandra Timofte, et al.
Cureus (2025)
Open Access
Expanding role of immunotherapeutics in colon and pancreatic cancers and managing their adverse effects
Syed Shahrukh Rizvi, Michael Gianarakis, John Pueringer, et al.
Elsevier eBooks (2025), pp. 363-388
Closed Access
Immune-related adverse events with PD-1/PD-L1 inhibitors: insights from a real-world cohort of 2523 patients
Ting Yan, Minghui Long, Chaoyi Liu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Exploring Immune Checkpoint Inhibitors: Focus on PD-1/PD-L1 Axis and Beyond
Durre Aden, Samreen Zaheer, Niti Sureka, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155864-155864
Closed Access
Case Report and Literature Review on Skin Toxicity Induced by PD-1 Inhibitor in a Penile Cancer with Massive Ulceration of Chemoradiotherapy-Resistant and Successful Treatment by Immunotherapy
Yanyan Zhu, Daxia Cai, Jiangle Jiang, et al.
Clinical Cosmetic and Investigational Dermatology (2025) Vol. Volume 18, pp. 699-707
Open Access
Rare Immuno-Induced Keratoacanthomas Showed on 18F-FDG PET/CT in a Metastatic Melanoma Patient
Naia Oillarburu, Cécile Pagès, V. Sibaud, et al.
Clinical Nuclear Medicine (2025) Vol. 50, Iss. 5, pp. e288-e289
Closed Access
Dermatologic toxicities related to cancer immunotherapy
Yosra Vaez-Gharamaleki, Mohammad Amin Akbarzadeh, Farhad Jadidi‐Niaragh, et al.
Toxicology Reports (2025), pp. 102021-102021
Open Access
Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database
Zhiyong Dong, M. He, Y. Hu
Dermatologic Therapy (2025) Vol. 2025, Iss. 1
Open Access
Pembrolizumab-induced Stevens-Johnson syndrome
Hiram Larangeira de Almeida, Débora Sarzi Sartori, Aline Paganelli, et al.
Anais Brasileiros de Dermatologia (2025)
Open Access
Immunotherapy Complications
Alexa Meara, Jaclyn Zois, Jason J. Bischof
Emergency Medicine Clinics of North America (2025)
Closed Access
Auswahl des Biopsieverfahrens – kritisch für die dermatopathologische Diagnostik
Almut Böer‐Auer, Christian Rosé
Deleted Journal (2025)
Closed Access
Immune Checkpoint Inhibitors in Field Cancerization and Keratinocyte Cancer Prevention
Charlotte V. Cox, Susan D. Brown, Euan Walpole, et al.
JAMA Dermatology (2025)
Open Access
Immunotherapy-induced psoriasis successfully treated with Guselkumab in a patient with metastatic gastric cancer
Denis Miyashiro, Thiago William Carnier Jorge, André Luís da Silva Hirayama, et al.
Anais Brasileiros de Dermatologia (2025)
Open Access
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
Yu Hua Chen, Tamás Kovács, Péter Ferdinandy, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 3
Fever of unknown origin associated with immune checkpoint inhibitors
Tong Xu, Tao Zhan, Xiaoqin Dong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Tissue‐resident memory T cells in immunotherapy and immune‐related adverse events by immune checkpoint inhibitor
Hao Xiong, Zhu Shen
International Journal of Cancer (2024) Vol. 155, Iss. 2, pp. 193-202
Closed Access | Times Cited: 2
Increased incidence of co-trimoxazole-induced rash in patients on systemic corticosteroid treatment for toxicity associated with immune checkpoint inhibitors
Daniel Yiu, Silvia Aguilar-Durán, Charlotte Edwards, et al.
British Journal of Dermatology (2024) Vol. 191, Iss. 3, pp. 465-467
Closed Access | Times Cited: 2
Immunological landscape of solid cancer: Interplay between tumor and autoimmunity
Ajay Singh, Phaneendra K. Duddempudi, Divya Kenchappa, et al.
International review of cell and molecular biology (2024), pp. 163-235
Closed Access | Times Cited: 2
Psoriasis in the Era of Targeted Cancer Therapeutics: A Systematic Review on De Novo and Pre-existing Psoriasis in Oncologic Patients Treated with Emerging Anti-neoplastic Agents
Vrinda Madan, Laura I. Ortiz‐López, Goranit Sakunchotpanit, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 7, pp. 1755-1766
Open Access | Times Cited: 2
Exploring the clinical significance of specific immune-related adverse events in melanoma patients undergoing immune checkpoint inhibitor therapy
Nethanel Asher, Neta Bar-Hai, Guy Ben‐Betzalel, et al.
Melanoma Research (2024)
Open Access | Times Cited: 2
Frequency and consequences of immune checkpoint inhibitor-associated inflammatory changes in different organs: an autopsy study over 13-years
Umberto Macciò, Andreas Wicki, Frank Ruschitzka, et al.
Modern Pathology (2024), pp. 100683-100683
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top